摘要
Artificial Intelligence(AI)has increased as a potent tool in medicine,with promising oncology applications.The emergence of immunotherapy has transformed the treatment terrain for hepatocellular carcinoma(HCC),offering new hope to patients with this challenging malignancy.This article examines the role and future of AI in forecasting the effectiveness of immunotherapy in HCC.We highlight the potential of AI to revolutionize the prediction of therapy response,thus improving patient selection and clinical outcomes.The article further outlines the challenges and future research directions in this emerging field.
基金
Supported by the National Natural Science Foundation of China,No.81401988
China Postdoctoral Science Foundation,No.2019M661907
Jiangsu Postdoctoral Science Foundation,No.2019K159,and No.2019Z153
General Project of Jiangsu Provincial Health Committee,No.H2023136
General Project of Nantong Municipal Health Committee,No.MS2023013
Jiangsu Provincial Research Hospital,No.YJXYY202204-YSB28
and College Student Innovation Program,No.202210304128Y,and No.2023103041055.
